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background: The majority of patients with heart failure with preserved ejection fraction (HFPEF) have metabolic comorbidities, such as obesity 
and diabetes mellitus (DM). Diastolic dysfunction was associated with increased titin-based stiffness in a recently published metabolic risk-induced 
rat model of HFPEF. The importance of a proinflammatory state, as observed in obesity and DM, and its contribution to diastolic dysfunction was 
investigated in this model.
Methods: Four groups or rats (Wystar Kyoto; lean ZSF1; obese ZSF1; and obese ZSF1 with high fat diet) were followed over 20 weeks with 
repeat metabolic, renal and echocardiographic evaluations and hemodynamically assessed at sacrifice (n=11/group). Hydrogen peroxide (H2O2), 
Interleukin 6 (IL 6) and tumor necrosis factor α (TNFα) were quantified in plasma. PKG activity and cGMP concentration were assessed in 
myocardial homogenates. Myocardial CD68, myeloperoxidase (MPO) and NOX2 expression were immuohistochemically quantified. Immunogold 
labeled electron microscopy was used to assess nitrotyrosine expression, as a marker of oxidative stress, in cardiomyocytes compared to 
endothelium.
results: ZSF1 obese rats developed DM and a systemic proinflammatory state with high circulating protein levels of IL6 and TNFα and higher 
levels of H2O2. On the cardiac level, expression levels of CD68 and MPO positive cells were increased and NOX2 was elevated in obese rats. In 
addition, inflammation can lead to low nitric oxide (NO) bioavailability, which was evident from lower nitrotyrosine expression in the endothelial 
regions. Low NO-bioavailability resulted in reduction of cGMP and PKG activity in obese rats. Deficiency of NO-cGMP-PKG signaling from endothelium 
to myocardium was associated with increased cardiomyocyte passive stiffness and titin hypophosphorylation in obese animals compared to controls.
conclusion: In HFPEF, obesity and DM contribute to systemic inflammation, which induces oxidative stress in the coronary microvascular 
endothelium mainly through deficient NO bioavailability. This causes reduced PKG activity, titin hypophosphorylation and thereby increased 
cardiomyocyte passive stiffness.
